Pharmaceutical Drugs And Biologics Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：350頁
文件格式：PDF
價 格：
USD 8,000 (Single-User License)
USD 12,000 (Multi-User License)
USD 16,000 (Global-User License)
USD 8,000 (Hard copy)
USD 12,000 (Multi-User License)
USD 16,000 (Global-User License)
USD 8,000 (Hard copy)
The pharmaceuticals industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs for medications. Pharmaceuticals are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing of drugs.
Pharmaceutical companies produce biological products, pharmaceutical preparations and medicinal and botanical products.
The global pharmaceutical market is expected to reach over $1300 billion in 2020. one of the key drivers of the pharmaceuticals market during 2016-2020 is expected to include 'New Methods For Drug Discovery'. Stem cells and organ on chip technologies are changing the way drug trials are being conducted. Organ on chips are micro-engineered biometric systems that simulates activities, mechanics and physiological response of organ systems. Drug trial processes such as target identification, validation, target based screening and phenotypic screening are being done through organ on chip and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Therefore, low drug discovery costs and accurate results generated from these technologies is expected to drive the pharmaceuticals market.
The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.
One of the top trends that is observed in the pharmaceuticals market include 'Turning Away From Animal Testing'. The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.
Pharmaceutical companies produce biological products, pharmaceutical preparations and medicinal and botanical products.
The global pharmaceutical market is expected to reach over $1300 billion in 2020. one of the key drivers of the pharmaceuticals market during 2016-2020 is expected to include 'New Methods For Drug Discovery'. Stem cells and organ on chip technologies are changing the way drug trials are being conducted. Organ on chips are micro-engineered biometric systems that simulates activities, mechanics and physiological response of organ systems. Drug trial processes such as target identification, validation, target based screening and phenotypic screening are being done through organ on chip and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Therefore, low drug discovery costs and accurate results generated from these technologies is expected to drive the pharmaceuticals market.
The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.
One of the top trends that is observed in the pharmaceuticals market include 'Turning Away From Animal Testing'. The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.
1. Pharmaceutical Drugs And Biologics Market Characteristics;
2. Pharmaceutical Drugs And Biologics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; Aging Populations; Emerging Markets Growth; Health Insurance Reforms; 2.1.2. Restraints On The Market; Patent Expiration Of Drugs; Pricing Pressures From Regulators; High Costs Of Drug Approval; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; Economic Growth; Technology; Changes In Lifestyles; New Methods For Drug Discovery; 2.2.2. Restraints On The Market; Cost; Interest Rate Increases; Reduction In Free Trade;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs And Biologics Market Customer Information;
5. Pharmaceutical Drugs And Biologics Market Segmentation;
5.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 5.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Pharmaceutical Drugs And Biologics Market Trends And Strategies; Turning Away From Animal Testing; Increase In Personalized Medicine; Collaboration Driving Innovation; Increase In Mergers And Acquisitions; Rise Of Biologics/Gene Therapy; Aggressive Pricing Changes In Some Drugs; 5.4 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016; 5.5 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Pharmaceutical Drugs; 5.8.1. Market Characteristics; 5.8.2. Global Pharmaceutical Drugs Market, 2016, By Segment; 5.8.3. Global Pharmaceutical Drugs Market, 2012 – 2020, Historic and Forecast, By Segment; 5.8.4. Market Trends And Strategies; 5.9 Biologics; 5.9.1. Market Characteristics; 5.9.2. Global Biologics Market, 2016, By Segment; 5.9.3. Global Biologics Market, 2012 – 2020, Historic and Forecast, By Segment; 5.9.4. Market Trends And Strategies;
6. Pharmaceutical Drugs And Biologics Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs And Biologics Market, 2016, By Country; 6.4. Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global;
8. Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country;
9. Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.10. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.11. Global Number Of Pharmacies, 2016, By Country; 9.12. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.13. Global New Drug Approvals, 2016, By Country; 9.14. Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.15. Global Number Of General Practitioners 2016, By Country; 9.16. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs And Biologics Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs And Biologics Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.2. Asia-Pacific Pharmaceutical Drugs And Biologics Market: Country Analysis; 10.3. China Pharmaceutical Drugs And Biologics Market; 10.3.1. China Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.3.3. China Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.3.4. China Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.3.5. China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.4. India Pharmaceutical Drugs And Biologics Market; 10.4.1. India Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.4.3. India Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.4.4. India Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.4.5. India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.5. Japan Pharmaceutical Drugs And Biologics Market; 10.5.1. Japan Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.5.3. Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.5.4. Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.5.5. Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.5.7. Japan Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.5.7.2. Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.6. Australia Pharmaceutical Drugs And Biologics Market; 10.6.1. Australia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.6.2. Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.6.3. Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.6.4. Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
11. Western Europe Pharmaceutical Drugs And Biologics Market;
11.1.1. Western Europe Pharmaceutical Drugs And Biologics Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.1.3. Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.1.4. Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.2. Western Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 11.3. UK Pharmaceutical Drugs And Biologics Market; 11.3.1. UK Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.3.3. UK Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.3.4. UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.3.5. UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.3.7. UK Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.3.7.2 UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4. Germany Pharmaceutical Drugs And Biologics Market; 11.4.1. Germany Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.4.2. Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.4.3. Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.4.4 Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.4.6 Germany Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4.7.2 Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5 France Pharmaceutical Drugs And Biologics Market; 11.5.1 France Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.5.2 France Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.5.3 France Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.5.4 France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.5.6 France Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5.6.2 France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6.1. Italy Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.6.2. Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.6.3. Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.6.4. Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.6.6. Italy Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6.6.2 Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7. Spain Pharmaceutical Drugs And Biologics Market; 11.7.1. Spain Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.7.2. Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.7.3. Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.7.4. Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.7.6. Spain Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7.6.2 Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
12. Eastern Europe Pharmaceutical Drugs And Biologics Market;
12.1.1. Eastern Europe Pharmaceutical Drugs And Biologics Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.2. Eastern Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs And Biologics Market; 12.3.1. Russia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 12.3.2. Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 12.3.3. Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.3.4. Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
13. North America Pharmaceutical Drugs And Biologics Market;
13.1.1. North America Pharmaceutical Drugs And Biologics Market Overview; 13.1.2. North America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 13.1.3. North America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 13.1.4. North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.2. North America Pharmaceutical Drugs And Biologics Market: Country Analysis; 13.3. USA Pharmaceutical Drugs And Biologics Market; 13.3.1. USA Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 13.3.2. USA Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 13.3.3 USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.3.4. USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 13.3.6. USA Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 13.3.6.2 USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
14. South America Pharmaceutical Drugs And Biologics Market;
14.1.1. South America Pharmaceutical Drugs And Biologics Market Overview; 14.1.2. South America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 14.1.3. South America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 14.1.4. South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.2. South America Pharmaceutical Drugs And Biologics Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs And Biologics Market; 14.3.1. Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 14.3.2. Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 14.3.3. Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.3.4. Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
15. Middle East Pharmaceutical Drugs And Biologics Market;
15.1.1. Middle East Pharmaceutical Drugs And Biologics Market Overview; 15.1.2. Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 15.1.3. Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 15.1.4. Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs;
16. Africa Pharmaceutical Drugs And Biologics Market;
16.1.1. Africa Pharmaceutical Drugs And Biologics Market Overview; 16.1.2. Africa Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 16.1.3. Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 16.1.4. Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Pharmaceutical Drugs;
17. Pharmaceutical Drugs And Biologics Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Roche; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Glaxosmithkline; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Merck & Co.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs And Biologics Market;
19. Market Background: Healthcare Market;
19.1.1. Healthcare Market Characteristics; 19.1.2. Healthcare Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Healthcare Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Healthcare Trends And Strategies; 19.2. Healthcare Market Regional And Country Analysis; 19.2.1. Global Healthcare Market, 2016, By Region; 19.2.2. Global Healthcare Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Healthcare Market, 2016, By Country; 19.2.4. Healthcare Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Healthcare Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Healthcare Market Comparison With Macro Economic Factors; 19.3.1. Healthcare Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Healthcare Expenditure, Global; 19.4. Healthcare Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Healthcare Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Healthcare Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Healthcare Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Pharmaceutical Drugs And Biologics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; Aging Populations; Emerging Markets Growth; Health Insurance Reforms; 2.1.2. Restraints On The Market; Patent Expiration Of Drugs; Pricing Pressures From Regulators; High Costs Of Drug Approval; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; Economic Growth; Technology; Changes In Lifestyles; New Methods For Drug Discovery; 2.2.2. Restraints On The Market; Cost; Interest Rate Increases; Reduction In Free Trade;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs And Biologics Market Customer Information;
5. Pharmaceutical Drugs And Biologics Market Segmentation;
5.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 5.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Pharmaceutical Drugs And Biologics Market Trends And Strategies; Turning Away From Animal Testing; Increase In Personalized Medicine; Collaboration Driving Innovation; Increase In Mergers And Acquisitions; Rise Of Biologics/Gene Therapy; Aggressive Pricing Changes In Some Drugs; 5.4 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016; 5.5 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Pharmaceutical Drugs; 5.8.1. Market Characteristics; 5.8.2. Global Pharmaceutical Drugs Market, 2016, By Segment; 5.8.3. Global Pharmaceutical Drugs Market, 2012 – 2020, Historic and Forecast, By Segment; 5.8.4. Market Trends And Strategies; 5.9 Biologics; 5.9.1. Market Characteristics; 5.9.2. Global Biologics Market, 2016, By Segment; 5.9.3. Global Biologics Market, 2012 – 2020, Historic and Forecast, By Segment; 5.9.4. Market Trends And Strategies;
6. Pharmaceutical Drugs And Biologics Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs And Biologics Market, 2016, By Country; 6.4. Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global;
8. Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country;
9. Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.10. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.11. Global Number Of Pharmacies, 2016, By Country; 9.12. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.13. Global New Drug Approvals, 2016, By Country; 9.14. Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.15. Global Number Of General Practitioners 2016, By Country; 9.16. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs And Biologics Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs And Biologics Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.2. Asia-Pacific Pharmaceutical Drugs And Biologics Market: Country Analysis; 10.3. China Pharmaceutical Drugs And Biologics Market; 10.3.1. China Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.3.3. China Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.3.4. China Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.3.5. China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.4. India Pharmaceutical Drugs And Biologics Market; 10.4.1. India Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.4.3. India Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.4.4. India Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.4.5. India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.5. Japan Pharmaceutical Drugs And Biologics Market; 10.5.1. Japan Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.5.3. Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.5.4. Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.5.5. Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.5.7. Japan Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.5.7.2. Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.6. Australia Pharmaceutical Drugs And Biologics Market; 10.6.1. Australia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.6.2. Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.6.3. Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.6.4. Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
11. Western Europe Pharmaceutical Drugs And Biologics Market;
11.1.1. Western Europe Pharmaceutical Drugs And Biologics Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.1.3. Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.1.4. Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.2. Western Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 11.3. UK Pharmaceutical Drugs And Biologics Market; 11.3.1. UK Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.3.3. UK Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.3.4. UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.3.5. UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.3.7. UK Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.3.7.2 UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4. Germany Pharmaceutical Drugs And Biologics Market; 11.4.1. Germany Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.4.2. Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.4.3. Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.4.4 Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.4.6 Germany Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4.7.2 Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5 France Pharmaceutical Drugs And Biologics Market; 11.5.1 France Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.5.2 France Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.5.3 France Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.5.4 France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.5.6 France Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5.6.2 France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6.1. Italy Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.6.2. Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.6.3. Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.6.4. Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.6.6. Italy Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6.6.2 Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7. Spain Pharmaceutical Drugs And Biologics Market; 11.7.1. Spain Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.7.2. Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.7.3. Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.7.4. Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.7.6. Spain Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7.6.2 Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
12. Eastern Europe Pharmaceutical Drugs And Biologics Market;
12.1.1. Eastern Europe Pharmaceutical Drugs And Biologics Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.2. Eastern Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs And Biologics Market; 12.3.1. Russia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 12.3.2. Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 12.3.3. Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.3.4. Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
13. North America Pharmaceutical Drugs And Biologics Market;
13.1.1. North America Pharmaceutical Drugs And Biologics Market Overview; 13.1.2. North America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 13.1.3. North America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 13.1.4. North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.2. North America Pharmaceutical Drugs And Biologics Market: Country Analysis; 13.3. USA Pharmaceutical Drugs And Biologics Market; 13.3.1. USA Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 13.3.2. USA Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 13.3.3 USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.3.4. USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 13.3.6. USA Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 13.3.6.2 USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
14. South America Pharmaceutical Drugs And Biologics Market;
14.1.1. South America Pharmaceutical Drugs And Biologics Market Overview; 14.1.2. South America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 14.1.3. South America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 14.1.4. South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.2. South America Pharmaceutical Drugs And Biologics Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs And Biologics Market; 14.3.1. Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 14.3.2. Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 14.3.3. Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.3.4. Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
15. Middle East Pharmaceutical Drugs And Biologics Market;
15.1.1. Middle East Pharmaceutical Drugs And Biologics Market Overview; 15.1.2. Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 15.1.3. Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 15.1.4. Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs;
16. Africa Pharmaceutical Drugs And Biologics Market;
16.1.1. Africa Pharmaceutical Drugs And Biologics Market Overview; 16.1.2. Africa Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 16.1.3. Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 16.1.4. Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Pharmaceutical Drugs;
17. Pharmaceutical Drugs And Biologics Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Roche; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Glaxosmithkline; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Merck & Co.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs And Biologics Market;
19. Market Background: Healthcare Market;
19.1.1. Healthcare Market Characteristics; 19.1.2. Healthcare Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Healthcare Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Healthcare Trends And Strategies; 19.2. Healthcare Market Regional And Country Analysis; 19.2.1. Global Healthcare Market, 2016, By Region; 19.2.2. Global Healthcare Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Healthcare Market, 2016, By Country; 19.2.4. Healthcare Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Healthcare Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Healthcare Market Comparison With Macro Economic Factors; 19.3.1. Healthcare Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Healthcare Expenditure, Global; 19.4. Healthcare Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Healthcare Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Healthcare Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Healthcare Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
